{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:17:09Z","timestamp":1792016229386,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"The Canadian Institutes for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pacific Alzheimer Research Foundation"},{"DOI":"10.13039\/100009836","name":"Huntington Society of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009836","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.nbd.2011.09.003","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T19:15:45Z","timestamp":1315941345000},"page":"438-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Sonia","family":"Franciosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae K.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaein","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colum","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"McLarnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair R.","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.09.003_bb0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneuroim.2008.06.011","article-title":"Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2.3-dioxygenase in response to peripheral lipopolysaccharide administration","volume":"200","author":"Andre","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2011.09.003_bb0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1179\/016164104225016272","article-title":"The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease","volume":"26","author":"Bailey","year":"2004","journal-title":"Neurol. Res."},{"key":"10.1016\/j.nbd.2011.09.003_bb0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbi.2009.09.001","article-title":"Minimal penetration of lipopolysaccharide across the murine blood\u2013brain barrier","volume":"24","author":"Banks","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2011.09.003_bb0020","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2011.09.003_bb0025","first-page":"4447","article-title":"Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide induced sickness behavior: a study with interleukin-1 type 1 receptor-deficient mice","volume":"12","author":"Bluthe","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.09.003_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0031-9384(00)00269-9","article-title":"Role of IL-6 in cytokine induced sickness behavior: a study with IL-6 deficient mice","volume":"70","author":"Bluthe","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.nbd.2011.09.003_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0891-0618(01)00093-X","article-title":"Length measurement: new developments in neurostereology and 3D imagery","volume":"21","author":"Calhoun","year":"2001","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.nbd.2011.09.003_bb0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10571-009-9477-0","article-title":"Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in mouse hippocampus","volume":"30","author":"Chung","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2011.09.003_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0306-4522(02)00030-1","article-title":"Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease","volume":"112","author":"Combrinck","year":"2002","journal-title":"Neurosci"},{"key":"10.1016\/j.nbd.2011.09.003_bb0050","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1523\/JNEUROSCI.2614-05.2005","article-title":"Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration","volume":"25","author":"Cunningham","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.09.003_bb0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1749-6632.1997.tb48386.x","article-title":"Microvascular responses to cerebral ischemia\/inflammation","volume":"823","author":"Del Zoppo","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2011.09.003_bb0245","doi-asserted-by":"crossref","unstructured":"Duran-Vilaregut J, Del Valle J, Manich G, Camins A, Pall\u00e0s M, Vilaplana J, Pelegr\u00ed C. Role of MMP-9 in striatal blood\u2013brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease. Neuropathol Appl Neurobiol Accepted manuscript online: 22 DEC 2010","DOI":"10.1111\/j.1365-2990.2010.01157.x"},{"key":"10.1016\/j.nbd.2011.09.003_bb0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s004010000195","article-title":"Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease","volume":"100","author":"Farkas","year":"2000","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.nbd.2011.09.003_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneumeth.2007.02.020","article-title":"Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain","volume":"163","author":"Franciosi","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2011.09.003_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0026-2862(02)00009-2","article-title":"Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood\u2013brain barrier in vitro","volume":"65","author":"Gaillard","year":"2003","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.nbd.2011.09.003_bb0080","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1096\/fj.05-3776fje","article-title":"Exaggerated neuroinflammation and sickness behaviour in aged mice following activation of the peripheral innate immune system","volume":"19","author":"Godbout","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2011.09.003_bb0085","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2011.09.003_bb0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archneur.1996.00550040044013","article-title":"Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease","volume":"53","author":"Harris","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.09.003_bb0095","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/122.9.1667","article-title":"Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease","volume":"122","author":"Harris","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.09.003_bb0100","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurol"},{"key":"10.1016\/j.nbd.2011.09.003_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/156720510793499039","article-title":"Converging perturbed microvasculature and microglial clusters characterize Alzheimer disease brain","volume":"7","author":"Jantaratnotai","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2011.09.003_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-8993(95)01250-8","article-title":"Increased collagen content of cerebral microvessels in Alzheimer's disease","volume":"705","author":"Kalaria","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.09.003_bb0115","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.09.003_bb0120","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00401-005-1003-y","article-title":"Stereological studies of capillary length density in the frontal cortex of schizophrenics","volume":"109","author":"Kreczmanski","year":"2005","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.nbd.2011.09.003_bb0125","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington's disease","volume":"117","author":"Moller","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.09.003_bb0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/ars.2009.2800","article-title":"HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease","volume":"12","author":"Niatsetskaya","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2011.09.003_bb0135","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1523\/JNEUROSCI.4786-03.2004","article-title":"Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis","volume":"24","author":"Nguyen","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.09.003_bb0140","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.peptides.2007.04.023","article-title":"Adipokines and the blood\u2013brain barrier","volume":"28","author":"Pan","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2011.09.003_bb0145","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20070304","article-title":"Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease","volume":"204","author":"Paul","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2011.09.003_bb0150","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease\u2014a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurol"},{"key":"10.1016\/j.nbd.2011.09.003_bb0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-010-0722-x","article-title":"Contribution of systemic inflammation to chronic neurodegeneration","volume":"120","author":"Perry","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2011.09.003_bb0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2011.09.003_bb0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.09.003_bb0170","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/j.1582-4934.2008.00434.x","article-title":"A leaky blood\u2013brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain","volume":"13","author":"Ryu","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.nbd.2011.09.003_bb0175","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0197-4580(03)00010-1","article-title":"Peripheral cytokine release in Alzheimer patients: correlation with disease severity","volume":"24","author":"Sala","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.09.003_bb0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington's disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.09.003_bb0185","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2011.09.003_bb0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tox.2004.04.015","article-title":"How does peripheral lipopolysaccharide induce gene expression in the brain of rats?","volume":"201","author":"Singh","year":"2004","journal-title":"Toxicology"},{"key":"10.1016\/j.nbd.2011.09.003_bb0195","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuron loss in YAC128 mouse model of Huntington's disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.09.003_bb0200","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0361-9230(01)00730-4","article-title":"Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"56","author":"Sly","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2011.09.003_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1755-5949.2008.00068.x","article-title":"Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease","volume":"15","author":"Squitieri","year":"2009","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2011.09.003_bb0210","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.09.003_bb0215","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(09)61158-2","article-title":"Systemic infection and delirium: when cytokines and acetylcholine collide","volume":"375","author":"Van Gool","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2011.09.003_bb0220","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbi.2005.10.005","article-title":"Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide","volume":"20","author":"Verma","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2011.09.003_bb0225","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1006\/cbir.1998.0388","article-title":"Connexin expression in Huntington's diseased human brain","volume":"22","author":"Vis","year":"1998","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.nbd.2011.09.003_bb0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(00)03247-9","article-title":"Effect of LPS on the permeability of the blood\u2013brain barrier to insulin","volume":"896","author":"Xaio","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.09.003_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn2336","article-title":"Neurovascular signaling defects in neurodegeneration","volume":"9","author":"Zacchigna","year":"2008","journal-title":"Nature Rev Neurosci"},{"key":"10.1016\/j.nbd.2011.09.003_bb0240","first-page":"13","article-title":"Molecular mechanism in tolerance to lipopolysaccharide","volume":"45","author":"Ziegler-Heitbrock","year":"1995","journal-title":"J. Inflamm."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111003007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111003007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:42:15Z","timestamp":1714660935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111003007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0969996111003007"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.09.003","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2011.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}